These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11899365)

  • 1. Trastuzumab for breast cancer-related carcinomatous meningitis.
    Robins HI; Liu G; Hayes L; Mehta M
    Clin Breast Cancer; 2002 Jan; 2(4):316. PubMed ID: 11899365
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of intrathecal trastuzumab in a patient with carcinomatous meningitis.
    Laufman LR; Forsthoefel KF
    Clin Breast Cancer; 2001 Oct; 2(3):235. PubMed ID: 11899418
    [No Abstract]   [Full Text] [Related]  

  • 3. Meningeal carcinomatosis from breast carcinoma responsive to trastuzumab.
    Baculi RH; Suki S; Nisbett J; Leeds N; Groves M
    J Clin Oncol; 2001 Jul; 19(13):3297-8. PubMed ID: 11432901
    [No Abstract]   [Full Text] [Related]  

  • 4. Correction: Meningeal carcinomatosis from breast carcinoma responsive to trastuzumab.
    Pestalozzi BC
    J Clin Oncol; 2001 Oct; 19(20):4091. PubMed ID: 11600616
    [No Abstract]   [Full Text] [Related]  

  • 5. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
    Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V
    Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment?].
    Gutierrez M; Lyazidi S; Brasseur L; Cvitkovic F; Le Scodan R
    Bull Cancer; 2011 Apr; 98(4):417-24. PubMed ID: 21540147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer.
    Mir O; Ropert S; Alexandre J; Lemare F; Goldwasser F
    Ann Oncol; 2008 Nov; 19(11):1978-80. PubMed ID: 18845838
    [No Abstract]   [Full Text] [Related]  

  • 8. Interventricular methotrexate therapy for carcinomatous meningitis due to breast cancer: a case with leukoencephalopathy.
    Hara H; Igarashi A; Yano Y; Yashiro T; Ueno E; Aiyoshi Y
    Breast Cancer; 2000; 7(3):247-51. PubMed ID: 11029806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancer.
    Ferrario C; Davidson A; Bouganim N; Aloyz R; Panasci LC
    Ann Oncol; 2009 Apr; 20(4):792-5. PubMed ID: 19223574
    [No Abstract]   [Full Text] [Related]  

  • 10. Meningeal carcinomatosis in HER2-overexpressing breast cancers.
    Bidard FC; Guilhaume MN; Gauthier H; Cottu PH; Diéras V; Pierga JY
    J Neurooncol; 2009 Jun; 93(2):287-8. PubMed ID: 19139826
    [No Abstract]   [Full Text] [Related]  

  • 11. [Meningeal carcinomatosis in cancer patients].
    Danova M; Invernizzi R
    Tumori; 2005; 91(5):10-21. PubMed ID: 16459648
    [No Abstract]   [Full Text] [Related]  

  • 12. [Carcinomatous meningitis revealing a cancer: study of two cases].
    Samet S; Belahsen F; Triki C; Masmoudi H; Jlidi R; Mhiri C
    Tunis Med; 2001 Apr; 79(4):257-60. PubMed ID: 11515489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab.
    Platini C; Long J; Walter S
    Lancet Oncol; 2006 Sep; 7(9):778-80. PubMed ID: 16945774
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypertrophic pachymeningitis carcinomtosa in a patient with the breast cancer].
    Kajimoto Y; Kihira T; Miwa H; Kondo T
    No To Shinkei; 2002 Jul; 54(7):626-7. PubMed ID: 12187724
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trastuzumab in metastatic breast carcinoma].
    Susnjar S; Bosnjak S; Radulovic S
    Srp Arh Celok Lek; 2001; 129(5-6):147-52. PubMed ID: 11797464
    [No Abstract]   [Full Text] [Related]  

  • 16. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
    Bendell JC; Domchek SM; Burstein HJ; Harris L; Younger J; Kuter I; Bunnell C; Rue M; Gelman R; Winer E
    Cancer; 2003 Jun; 97(12):2972-7. PubMed ID: 12784331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual presentation of carcinomatous meningitis: case report and review of typical CSF findings.
    Zeller JA; Zunker P; Witt K; Schlueter E; Deuschl G
    Neurol Res; 2002 Oct; 24(7):652-4. PubMed ID: 12392200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carcinomatous meningitis secondary to breast cancer. Spectacular response to hormone therapy].
    Andrés E; Goichot B; Kurtz JE; Dufour P; Imler M; Schlienger JL
    Presse Med; 1999 Jan; 28(2):75. PubMed ID: 9989298
    [No Abstract]   [Full Text] [Related]  

  • 19. [Early detection of leptomeningeal metastasis in patients with metastatic breast carcinoma: validation of CA 15-3 measurement in cerebrospinal fluid].
    Gauchez AS; Pez E; Boutonnat J; Bourre JC; Pelletier L; Payan R; Mousseau M
    Ann Biol Clin (Paris); 2007; 65(6):653-8. PubMed ID: 18039611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal trastuzumab: dose matters.
    Hofer S; Mengele K; Stemmler HJ; Schmitt M; Pestalozzi B
    Acta Oncol; 2012 Sep; 51(7):955-6. PubMed ID: 22524214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.